KishJ, DrelichmanA, JacobsJClinical trial of cisplatin and 5-FU infusion as initial treatment for advanced squamous cell carcinoma of the head and neck.Cancer Treat Rep1982; 66: 471–4.
2.
Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer.The Department of Veterans Affairs Laryngeal Cancer Study Group.N Engl J Med1991; 324: 1685–90.
3.
UrbaS, WolfG, EisbruchASingle-cycle induction chemotherapy selects patients with advanced laryngeal cancer for combined chemoradiation: a new treatment paradigm.J Clin Oncol2006; 24: 593–8.
4.
JanotF, RheinB, KokaVNPréservation laryngée par chimiothérapie d'induction. À propos de l'expérience des deux centres du GETTEC dans les cancers de l'endolarynx traités entre 1985 et 1995.Ann Otolaryngol Chir Cervicofac2002; 119: 12–20.
5.
RapidisAD, TrichasM, StavrinidisEInduction chemotherapy followed by concurrent chemoradiation in advanced squamous cell carcinoma of the head and neck: final results from a phase II study with docetaxel, cisplatin and 5-fluorouracil with a four-year follow-up.Oral Oncol2006; 42: 675–84.
6.
VermorkenJB, RemenarE, van HerpenCCisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer.N Engl J Med2007; 357: 1695–704.
7.
PointreauY, GaraudP, ChapetSRandomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation.J Natl Cancer Inst2009; 101: 498–506.
8.
ForastiereAA, GoepfertH, MaorMConcurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer.N Engl J Med2003; 349: 2091–8.
9.
BonnerJA, HarariPM, GiraltJRadiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck.N Engl J Med2006; 354: 567–78.
LaccourreyeO, VeiversD, HansS, MénardM, BrasnuD, LaccourreyeH,. Chemotherapy alone with curative intent in patients with invasive squamous cell carcinoma of the pharyngolarynx classified as T1-T4N0M0 complete clinical responders.Cancer2001; 92: 1504–11.
12.
LaccourreyeO, VeiversD, BassotV, MénardM, BrasnuD, LaccourreyeH,. Analysis of local recurrence in patients with selected T1-T3N0M0 squamous cell carcinoma of the true vocal cord managed with a platinum-based chemotherapy-alone regimen for cure.Ann Otol Rhinol Laryngol2002; 111: 315–22.
13.
VachinF, HansS, AtlanD, BrasnuD, MénardM, LaccourreyeO,. Résultats à long-terme de la chimiothérapie exclusive des cancers épidermoïdes glottiques.Ann Otolaryngol Chir Cervicofac2004; 121: 140–7.
HolsingerFC, KiesMS, DiazEMJr.Durable long-term remission with chemotherapy alone for stage II to IV laryngeal cancer.J Clin Oncol2009; 27: 1976–82.
16.
OkenMM, CreechRH, TormeyDCToxicity and response criteria of the Eastern Cooperative Oncology Group.Am J Clin Oncol1982; 5: 649–55.
17.
HartlDM, BrasnuDF, FriedMP.Conservation surgery for glottic cancer. In: FriedMP, FerlitoA, eds. The larynx.3rd ed. Vol 2.San Diego, Calif: Plural Publishing, 2009; 515–43.
18.
WilliamWNJr., KimES, HerbstRS,. Cetuximab therapy for patients with advanced squamous cell carcinomas of the head and neck.Nat Clin Pract Oncol2009; 6: 132–3.
19.
ForastiereAA, ShahaAR.Chemotherapy alone for laryngeal preservation — is it possible [Editorial]?J Clin Oncol2009; 27: 1933–4.
